Tag #Heart Failure

Showing 1 to 12 of 19 results

euronews.com

🌐 85% Global Worthiness

Sep 1, 13:14

AI-Powered Stethoscope Improves Heart Condition Detection

A study involving over 1.5 million patients in 200 UK general practitioner offices revealed that an AI-powered stethoscope can significantly improve the detection rates of heart failure, atrial fibrillation, and heart valve disease within 15 seconds, although it also resulted in some false positives...

AI-Powered Stethoscope Improves Heart Condition Detection

A study involving over 1.5 million patients in 200 UK general practitioner offices revealed that an AI-powered stethoscope can significantly improve the detection rates of heart failure, atrial fibrillation, and heart valve disease within 15 seconds, although it also resulted in some false positives...

Progress

16% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the broader implications and limitations of using this AI diagnostic tool?

While significantly improving detection rates, the AI stethoscope produced false positives in approximately two-thirds of suspected heart failure cases, potentially causing unnecessary anxiety and tests. Its effectiveness is also hampered by the fact that 70% of GP offices stopped using it regularly after one year.

dailymail.co.uk

🌐 85% Global Worthiness

Aug 25, 22:18

MASLD Linked to Heart Failure in Millions of Americans

Duke University research reveals a significant link between MASLD and heart failure, affecting nearly 90 million Americans; almost half showed early heart damage, and 12.5% of patients died within an 11-year period.

MASLD Linked to Heart Failure in Millions of Americans

Duke University research reveals a significant link between MASLD and heart failure, affecting nearly 90 million Americans; almost half showed early heart damage, and 12.5% of patients died within an 11-year period.

Progress

16% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the critical underdiagnosis problem revealed by the study concerning MASLD patients and heart failure?

New research from Duke University reveals a strong link between MASLD (affecting over 86 million Americans) and heart failure. Nearly half of the 570 patients studied showed early heart damage, and almost 20% developed heart failure within 11 years, highlighting a significant underdiagnosis problem.

kathimerini.gr

🌐 85% Global Worthiness

Jun 10, 10:11

SGLT-2 Inhibitors Added to Heart Failure Treatment Guidelines

New guidelines recommend SGLT-2 inhibitors for heart failure patients, improving outcomes and reducing hospitalizations; studies show reduced death and hospitalization risks compared to standard care; this is due to their diuretic effects and positive impact on kidney function, thus benefiting both ...

SGLT-2 Inhibitors Added to Heart Failure Treatment Guidelines

New guidelines recommend SGLT-2 inhibitors for heart failure patients, improving outcomes and reducing hospitalizations; studies show reduced death and hospitalization risks compared to standard care; this is due to their diuretic effects and positive impact on kidney function, thus benefiting both ...

Progress

28% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How do SGLT-2 inhibitors impact heart failure patients, and what evidence supports their efficacy?

The addition of SGLT-2 inhibitors to heart failure treatment significantly alters the therapeutic landscape. Studies published in The New England Journal of Medicine (October 14, 2021) and The Lancet (September 19, 2020) demonstrate reduced risks of death and hospitalization in patients with both HFrEF and HFpEF who received SGLT-2 inhibitors, compared to those receiving standard care. This improvement is attributed to SGLT-2 inhibitors' diuretic effect, sodium level reduction, and weight loss benefits, alongside their positive impact on kidney function.

jpost.com

🌐 85% Global Worthiness

May 25, 07:09

Higher-Normal Sodium Levels Linked to Increased Hypertension and Heart Failure Risk

A Bar-Ilan University study of 407,000 healthy adults found a 13% higher hypertension risk and a 20% higher heart failure risk for those with sodium levels of 140-142 mmol/L, suggesting that adequate hydration is crucial for cardiovascular health and challenging existing understandings of normal sod...

Higher-Normal Sodium Levels Linked to Increased Hypertension and Heart Failure Risk

A Bar-Ilan University study of 407,000 healthy adults found a 13% higher hypertension risk and a 20% higher heart failure risk for those with sodium levels of 140-142 mmol/L, suggesting that adequate hydration is crucial for cardiovascular health and challenging existing understandings of normal sod...

Progress

36% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the direct impact of higher-normal serum sodium levels on the risk of hypertension and heart failure among seemingly healthy adults, as evidenced by the Bar-Ilan University study?

A recent Bar-Ilan University study analyzed electronic health records of 407,000 healthy adults, revealing a 13% higher hypertension risk and a 20% higher heart failure risk for those with sodium levels between 140-142 mmol/L (within the normal range). Almost 60% of participants fell into this risk category. This highlights the significance of hydration in cardiovascular health, even among seemingly healthy individuals.

nos.nl

🌐 65% Global Worthiness

Apr 14, 16:12

Netherlands Launches Study to Improve Heart Failure Treatment

In the Netherlands, roughly 60 percent of heart failure patients don't receive the four-drug combination proven to improve quality of life, leading to a large-scale research project to better implement this treatment and raise awareness, addressing issues like patient comorbidities and physician com...

Netherlands Launches Study to Improve Heart Failure Treatment

In the Netherlands, roughly 60 percent of heart failure patients don't receive the four-drug combination proven to improve quality of life, leading to a large-scale research project to better implement this treatment and raise awareness, addressing issues like patient comorbidities and physician com...

Progress

36% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How do patient characteristics, such as age and comorbidities, influence medication choices and treatment effectiveness in heart failure?

The study aims to address the suboptimal treatment of heart failure, where only 40 percent of patients receive the four-drug combination proven most effective. Factors hindering broader adoption include patient age, comorbidities (like kidney issues or diabetes), and the fear of side effects, particularly from blood pressure medication. Improved physician communication about the benefits of the combination is crucial.

dw.com

🌐 75% Global Worthiness

Mar 28, 10:11

Takotsubo Syndrome Research Reveals Physical Triggers and High Mortality

Gabriella K. experienced Takotsubo syndrome, a sudden heart weakness mimicking a heart attack, during dinner. German researchers are investigating its causes, finding that physical triggers are more common than emotional ones, with mortality rates similar to heart attacks.

Takotsubo Syndrome Research Reveals Physical Triggers and High Mortality

Gabriella K. experienced Takotsubo syndrome, a sudden heart weakness mimicking a heart attack, during dinner. German researchers are investigating its causes, finding that physical triggers are more common than emotional ones, with mortality rates similar to heart attacks.

Progress

44% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the immediate consequences and global significance of Takotsubo syndrome's misdiagnosis as a heart attack?

Takotsubo syndrome, also known as Broken Heart Syndrome, causes sudden, temporary heart weakness mimicking a heart attack. German researchers are investigating its causes, with new findings shedding light on this rare condition. One patient, Gabriella K., lost consciousness during dinner, experiencing dizziness and shortness of breath before collapsing.

theguardian.com

🌐 90% Global Worthiness

Aug 31, 13:16

Weight-Loss Drugs Halve Heart Failure Hospitalizations and Deaths

A large-scale study reveals that GLP-1 agonists, semaglutide and tirzepatide, significantly reduce hospitalizations and mortality risk by 42% and 58%, respectively, in obese heart failure patients with type 2 diabetes.

Weight-Loss Drugs Halve Heart Failure Hospitalizations and Deaths

A large-scale study reveals that GLP-1 agonists, semaglutide and tirzepatide, significantly reduce hospitalizations and mortality risk by 42% and 58%, respectively, in obese heart failure patients with type 2 diabetes.

Progress

32% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How do these findings expand our understanding of GLP-1 agonists' effects beyond weight loss?

While initially developed for diabetes, this research indicates substantial cardiovascular benefits. The reduced hospitalization and mortality rates suggest mechanisms beyond weight loss, offering a new treatment avenue for heart failure.

dailymail.co.uk

🌐 85% Global Worthiness

Aug 8, 19:17

Pregabalin Linked to Increased Heart Failure Risk

A new study revealed a significantly increased risk of heart failure among pregabalin users, prompting doctors to reassess its prescription, especially in older patients with pre-existing heart conditions.

Pregabalin Linked to Increased Heart Failure Risk

A new study revealed a significantly increased risk of heart failure among pregabalin users, prompting doctors to reassess its prescription, especially in older patients with pre-existing heart conditions.

Progress

36% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the immediate impact of the new research linking pregabalin to increased heart failure risk?

A major study linked the painkiller pregabalin to a 48% increased heart failure risk, rising to 85% in patients with pre-existing heart conditions. Doctors are urged to reassess its use, especially in older patients, carefully weighing the cardiovascular risks against benefits.

news.sky.com

🌐 85% Global Worthiness

Jun 4, 07:10

AI Foot Scanner Detects Worsening Heart Failure 13 Days Before Hospitalization

A new AI-powered foot scanner, developed by Heartfelt Technologies, can detect worsening heart failure up to 13 days before hospital admission, potentially improving patient outcomes and reducing healthcare costs.

AI Foot Scanner Detects Worsening Heart Failure 13 Days Before Hospitalization

A new AI-powered foot scanner, developed by Heartfelt Technologies, can detect worsening heart failure up to 13 days before hospital admission, potentially improving patient outcomes and reducing healthcare costs.

Progress

36% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the limitations of current heart failure monitoring methods compared to the AI foot scanner, and how does this new technology address those limitations?

The study, involving 26 heart failure patients, showed the scanner triggered alerts an average of 13 days before hospital admission, significantly outperforming weight self-monitoring. This highlights the potential of AI-driven home monitoring in improving heart failure management and reducing hospital strain. The device's success is especially important considering only about half of heart failure patients currently receive timely reviews from nurses.

spanish.china.org.cn

🌐 85% Global Worthiness

Apr 17, 16:15

World's Youngest Receives Tiny Artificial Heart in China

A 7-year-old child in Wuhan, China, became the youngest person globally to receive a magnetically levitated biventricular assist device, a 45-gram artificial heart, offering hope in the face of a critical shortage of donor organs for pediatric heart transplants.

World's Youngest Receives Tiny Artificial Heart in China

A 7-year-old child in Wuhan, China, became the youngest person globally to receive a magnetically levitated biventricular assist device, a 45-gram artificial heart, offering hope in the face of a critical shortage of donor organs for pediatric heart transplants.

Progress

36% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How does Junjun's case illuminate the challenges of pediatric heart transplantation in China, and what potential solutions does this technology offer?

Junjun's case highlights the critical shortage of donor hearts for pediatric heart transplants in China, where only less than 100 such procedures are performed annually despite 40,000 children being hospitalized each year for severe heart failure. This innovative device offers a potential solution for bridging the gap between diagnosis and transplantation, significantly improving survival rates.

elmundo.es

🌐 85% Global Worthiness

Mar 29, 22:12

Dapagliflozin Improves Outcomes in Post-TAVI Aortic Stenosis Patients

A clinical trial involving 1,250 patients with severe aortic stenosis demonstrated that dapagliflozin, an SGLT-2 inhibitor, significantly reduced mortality and hospital readmissions for heart failure following transcatheter aortic valve implantation (TAVI), prompting calls for updated clinical guide...

Dapagliflozin Improves Outcomes in Post-TAVI Aortic Stenosis Patients

A clinical trial involving 1,250 patients with severe aortic stenosis demonstrated that dapagliflozin, an SGLT-2 inhibitor, significantly reduced mortality and hospital readmissions for heart failure following transcatheter aortic valve implantation (TAVI), prompting calls for updated clinical guide...

Progress

48% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How does this study address the limitations of previous research on SGLT-2 inhibitors and heart failure in elderly patients?

The DapaTAVI trial highlights the potential for dapagliflozin to improve the prognosis of patients with aortic stenosis after TAVI, a less invasive procedure for older patients. The study's success underscores the need to revise clinical guidelines to include SGLT-2 inhibitors as a standard post-TAVI treatment for high-risk patients. This is crucial given that up to 20% of post-TAVI patients experience heart failure or death within the first year.

smh.com.au

🌐 90% Global Worthiness

Mar 12, 04:11

World-First Levitating Heart Implant: Australian Patient Discharged

An Australian patient became the first globally to leave hospital with a levitating titanium heart implant, developed by Queenslander Daniel Timms, paving the way for a world-leading medical manufacturing industry in Australia and potentially halving deaths from cardiac failure.

World-First Levitating Heart Implant: Australian Patient Discharged

An Australian patient became the first globally to leave hospital with a levitating titanium heart implant, developed by Queenslander Daniel Timms, paving the way for a world-leading medical manufacturing industry in Australia and potentially halving deaths from cardiac failure.

Progress

40% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the immediate implications of this successful artificial heart implant for cardiac care and the Australian medical industry?

An Australian patient is the first to leave the hospital with a levitating titanium heart implant, a significant advancement in treating cardiac failure. The implant, developed by Daniel Timms, allowed the patient to survive until a traditional heart transplant. This success marks a major step towards reducing cardiac failure deaths and establishing a world-leading medical manufacturing sector in Australia.

Showing 1 to 12 of 19 results